Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00390_DB05521_nanopub.RAvIOORu2QH_0AX1EjIsy12YrLm5ne8CBOkApjYu33-KE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00390_DB05521 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00390_DB05521 label "DDI between Digoxin and Telaprevir - Telaprevir is a substrate of p-glycoprotein and thus increases the AUC and Cmax of digoxin. This indicates an increased absorption of digoxin. Lowest dose of digoxin should be used first and levels be closely monitored. [drugbank_resource:DB00390_DB05521]" assertion.
- drugbank_resource:DB00390_DB05521 identifier "drugbank_resource:DB00390_DB05521" assertion.
- drugbank_resource:DB00390_DB05521 title "DDI between Digoxin and Telaprevir - Telaprevir is a substrate of p-glycoprotein and thus increases the AUC and Cmax of digoxin. This indicates an increased absorption of digoxin. Lowest dose of digoxin should be used first and levels be closely monitored." assertion.
- drugbank:DB05521 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00390_DB05521 assertion.
- drugbank:DB00390 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00390_DB05521 assertion.